Global Central Venous Catheters Market Size By Type (Single-lumen, Double-lumen), By Application (Jugular Vein, Subclavian Vein), By Region, And Segment Forecasts, 2023 to 2032

The Global Central Venous Catheters Market was valued at USD 3.8 billion in 2023 and is projected to surpass USD 6.1 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023-2031. The market growth is primarily driven by the rising prevalence of chronic diseases, an increase in surgical procedures requiring central venous access, and the growing adoption of minimally invasive techniques in medical settings. Central venous catheters (CVCs) play a crucial role in critical care, oncology treatments, hemodialysis, and long-term intravenous therapies, thereby boosting market demand.

Market Drivers

1. Rising Prevalence of Chronic Diseases

The increasing burden of chronic diseases such as cancer, cardiovascular diseases, and kidney disorders has significantly increased the demand for central venous catheters. Patients undergoing chemotherapy, long-term intravenous antibiotic therapy, or dialysis often require CVCs for effective treatment administration.

2. Growth in Surgical and ICU Admissions

With the rise in surgical procedures and intensive care unit (ICU) admissions, the need for central venous catheters has increased. CVCs are widely used for the administration of fluids, medications, and blood products in critically ill patients, making them essential in healthcare settings.

3. Advancements in Catheter Technologies

Technological advancements such as the development of antimicrobial-coated catheters, heparin-coated catheters, and ultrasound-guided catheter placement techniques have enhanced the safety, durability, and effectiveness of CVCs, thereby driving market growth.

Market Restraints

1. Risk of Catheter-Related Infections

Despite advancements in catheter coatings and insertion techniques, catheter-related bloodstream infections (CRBSIs) remain a major concern, leading to potential complications and increased healthcare costs.

2. High Cost of Advanced Central Venous Catheters

Specialized CVCs, such as antimicrobial-coated catheters and tunneled catheters, come at a higher cost, which may limit their adoption in low- and middle-income countries.

3. Alternative Venous Access Devices

The growing adoption of peripherally inserted central catheters (PICCs) and implantable ports as alternatives to CVCs in certain medical conditions may pose a challenge to market growth.

Market Opportunity

1. Increasing Demand in Emerging Markets

The expansion of healthcare infrastructure in emerging economies such as India, China, and Brazil presents significant opportunities for market players. Rising healthcare investments and the adoption of advanced medical devices are expected to drive market demand.

2. Growth in Home Healthcare Services

With the increasing preference for home-based medical treatments, the demand for long-term intravenous therapy solutions using central venous catheters is rising. This shift is particularly beneficial for oncology, chronic kidney disease, and palliative care patients.

3. Development of Bioengineered Catheters

The emergence of biodegradable and bioengineered catheters with reduced infection risks and improved biocompatibility provides a lucrative opportunity for manufacturers in the market.

Market Segmentation

Market by System Type Insights

Non-Tunneled Catheters – Accounted for the largest market share in 2023, primarily due to their widespread use in emergency and critical care settings.

Tunneled Catheters – Expected to witness significant growth due to their long-term use in dialysis and chemotherapy patients.

Implantable Ports – Increasing adoption in oncology treatments as a preferred alternative for long-term intravenous therapy.

Peripherally Inserted Central Catheters (PICCs) – Gaining popularity due to their minimally invasive nature and lower infection risks.

Market by End-Use Insights

Hospitals & Surgical Centers – The dominant segment, accounting for over 50% of market revenue in 2023 due to the high number of surgical and critical care procedures.

Ambulatory Surgical Centers (ASCs) – Expected to register rapid growth with the increasing trend of outpatient medical procedures.

Home Healthcare Settings – Gaining traction due to the rising demand for long-term home-based therapies, particularly in the oncology and dialysis sectors.

Market by Regional Insights

1. North America – Largest Market Share

North America dominated the market in 2023, driven by:

High adoption of advanced CVCs.

Strong healthcare infrastructure.

Rising chronic disease burden, especially in the United States.

2. Europe – Strong Market Presence

Europe holds a substantial share due to:

Increasing ICU admissions and cancer treatments.

Stringent medical device regulations ensuring high product quality.

Presence of key market players driving innovation.

3. Asia-Pacific – Fastest Growing Market

Asia-Pacific is projected to experience the highest CAGR during 2023-2031, fueled by:

Rapid expansion of healthcare facilities in China, India, and Japan.

Increasing awareness and accessibility to advanced medical devices.

Government initiatives for improving healthcare services.

4. Latin America & Middle East & Africa (MEA)

These regions are witnessing gradual growth, driven by:

Growing investments in healthcare.

Expanding medical infrastructure in urban areas.

Increasing cases of chronic diseases and ICU admissions.

Competitive Scenario

Key players in the Global Central Venous Catheters Market include:

Becton, Dickinson and Company (BD)

Teleflex Incorporated

B. Braun Melsungen AG

Cook Medical

Edwards Lifesciences Corporation

Smiths Medical

Medtronic plc

AngioDynamics, Inc.

Vygon Group

Fresenius Medical Care

Recent Market Developments:

2023 – BD launched an advanced antimicrobial-coated central venous catheter to reduce bloodstream infections.

2024 – Teleflex expanded its catheter product portfolio with bioengineered materials for improved biocompatibility.

2025 – Medtronic partnered with leading hospitals in Asia-Pacific to introduce cost-effective central venous access solutions.

Scope of Work – Global Central Venous Catheters Market

Report Metric Details

Market Size (2023) USD 3.8 Billion

Projected Market Size (2031) USD 6.1 Billion

CAGR (2023-2031) 6.1%

Market Segments By System Type (Non-Tunneled, Tunneled, PICC, Implantable Ports), By End-Use (Hospitals, ASCs, Home Healthcare)

Growth Drivers Rising chronic disease prevalence, Increase in ICU admissions, Technological advancements

Opportunities Home healthcare expansion, Bioengineered catheters, Growth in emerging markets

FAQs

1. What is the current market size of the Global Central Venous Catheters Market?

The Global Central Venous Catheters Market was valued at USD 3.8 billion in 2023.

2. What is the major growth driver of the Global Central Venous Catheters Market?

The primary driver is the increasing prevalence of chronic diseases requiring long-term intravenous therapy, such as cancer, kidney disease, and cardiovascular disorders.

3. Which is the largest region during the forecast period in the Global Central Venous Catheters Market?

North America is expected to maintain the largest market share due to advanced healthcare infrastructure and high adoption of technologically advanced catheters.

4. Which segment accounted for the largest market share in the Global Central Venous Catheters Market?

The Non-Tunneled Catheters segment accounted for the largest share in 2023, driven by its widespread use in emergency and critical care settings.

5. Who are the key market players in the Global Central Venous Catheters Market?

Key players include BD, Teleflex, Medtronic, B. Braun, Cook Medical, and Smiths Medical.

This comprehensive report offers SEO-friendly, accurate, and insightful market research into the Global Central Venous Catheters Market for businesses, investors, and stakeholders.